Skip to content

YK-11

โ† Previous: xipamide | ๐Ÿ  All Substances | ๐Ÿ“Š Complete Table | Next: zaleplon โ†’

OPSS Properties

Classifications6000
ReasonWADA S1: Anabolic AgentsUnapproved drugFDA statement: SARMs
Also Known As
  • YK-11-OA
  • 19-norpregna-4,20-diene-21-carboxylic acid, 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-, methyl ester, (17alpha,20E)-
  • methyl(2E)-2-[(8R,9S,10R,13S,14S,17R)-2โ€™-methoxy-2โ€™,13-dimethyl-3-0x0spiro[1,2,6.7,8,9,10,11,12,14,15,16-dodecahydroyclopenta[
  • 19-norpregna-4,20-diene-21-carboxylic acid, 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-, methyl ester, (17ฮฑ,20E)-
  • YK-500
  • (17-ฮฑ,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3- oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester)
  • 17ฮฑ,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene- 21-carboxylic acid methyl ester
  • YK11 cpd
  • (17a,20E)-17,20-[(1-Methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester
  • YK11
  • YK 11
Prohibited BecauseWADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents)
Unapproved Drug
FDA Statement
Added to DatabaseDecember 30, 2025
Source Last UpdatedJuly 12, 2024
GUIDabf7848f-3428-4117-a0b8-5a4c578d4a3f

References

External Resources

UNII: Z9748J6B0R ยท CAS: 1370003-76-1

PubChem Properties

Chemical Structure

Interactive 3D Structure

Molecular FormulaC25H34O6
Molecular Weight430.5 g/mol
IUPAC Namemethyl (2E)-2-[(8R,9S,10R,13S,14S,17S)-2'-methoxy-2',13-dimethyl-3-oxospiro[1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,5'-1,3-dioxolane]-4'-ylidene]acetate
InChIKeyKCQHQCDHFVGNMK-PQUNLUOYSA-N

๐Ÿ“Š Complete Table | ๐Ÿ  All Substances

Substance 872 of 880